Home › STERIS CORPORATION › NA
NA
STERIS CORPORATION · Model enspire 3000 Maxflow Connector · UDI-DI 00724995229016
2
510(k) clearances
5,046
Adverse events (22 deaths)
40
Recalls
22
Facilities
Description
enspire 3000 MaxFlow Connector, ENLCS633
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2026-03-25 | Olympus Corporation of the Americas | Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely. |
| 2026-03-25 | Olympus Corporation of the Americas | Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely. |
| 2026-03-25 | Olympus Corporation of the Americas | XXX |
| 2026-03-25 | Olympus Corporation of the Americas | Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely. |
| 2026-03-25 | Olympus Corporation of the Americas | Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely. |
| 2026-03-25 | Olympus Corporation of the Americas | Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely. |
| 2026-03-25 | Olympus Corporation of the Americas | Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely. |
| 2026-03-25 | Olympus Corporation of the Americas | Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely. |
| 2026-03-25 | Olympus Corporation of the Americas | Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely. |
| 2026-03-25 | Olympus Corporation of the Americas | Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely. |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.
